Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failure

by Weerawat Manosuthi, Supeda Thongyen, Samruay Nilkamhang, Sukanya Manosuthi, Somnuek Sungkanuparph
Published 2018

HIV-1 drug resistance-associated mutations among antiretroviral-naive thai patients with chronic HIV-1 infection

by Weerawat Manosuthi, Supeda Thongyen, Samruay Nilkamhang, Sukanya Manosuthi, Somnuek Sungkanuparph
Published 2018

Comparison of thai government manufactured tenofovir (Tenofovir GPO300) with privately manufactured tenofovir (Viread) used along with lamivudine and efavirenz to treat Thai HIV pa...

by Weerawat Manosuthi, Supeda Thongyen, Samruay Nilkamhang, Sukanya Manosuthi, Somnuek Sungkanuparph
Published 2018

CYP2B6 18492T→C polymorphism compromises efavirenz concentration in coinfected HIV and tuberculosis patients carrying CYP2B6 haplotype *1/*1

by Weerawat Manosuthi, Chonlaphat Sukasem, Suped Thongyen, Samruay Nilkamhang, Sukanya Manosuthi, Somnuek Sungkanuparph
Published 2018

CYP2B6 haplotype and biological factors responsible for hepatotoxicity in HIV-infected patients receiving efavirenz-based antiretroviral therapy

by Weerawat Manosuthi, Chonlaphat Sukasem, Aroon Lueangniyomkul, Wiroj Mankatitham, Supeda Thongyen, Samruay Nilkamhang, Sukanya Manosuthi, Somnuek Sungkanuparph
Published 2018

Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients

by Weerawat Manosuthi, Chonlaphat Sukasem, Aroon Lueangniyomkul, Wiroj Mankatitham, Supeda Thongyen, Samruay Nilkamhang, Sukanya Manosuthi, Somnuek Sungkanuparph
Published 2018